These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 42024)

  • 1. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
    Robinson DS; Campbell IC; Walker M; Statham NJ; Lovenberg W; Murphy DL
    Neuropharmacology; 1979 Oct; 18(10):771-6. PubMed ID: 42024
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
    Davis JN; Carlsson A
    J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of methylmercury on brain biogenic amines in the developing rat pup.
    Taylor LL; DiStefano V
    Toxicol Appl Pharmacol; 1976 Dec; 38(3):489-97. PubMed ID: 13517
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors (MAOI) increase rat brain aromatic amino acid decarboxylase activity.
    Campbell IC; Murphy DL; Walker MN; Lovenberg W; Robinson DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):431-2. PubMed ID: 7378261
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei.
    Morgan ME; Gibb JW
    Neuropharmacology; 1980 Oct; 19(10):989-95. PubMed ID: 6106905
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase after inhibiting monoamine oxidase-A.
    Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1996 Oct; 314(1-2):51-9. PubMed ID: 8957218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT; Mozayani A; Danielson TJ; Baker GB
    J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetrahydrobiopterin and biogenic amine metabolism in the hph-1 mouse.
    Hyland K; Gunasekera RS; Engle T; Arnold LA
    J Neurochem; 1996 Aug; 67(2):752-9. PubMed ID: 8764604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase.
    Dyck LE; Juorio AV; Durden DA; Boulton AA
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):279-83. PubMed ID: 3393230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the optical isomers of the narcotic antagonist analgesic pentazocine on brain and heart biogenic amines.
    Berkowitz BA
    Eur J Pharmacol; 1974 May; 26(2):359-65. PubMed ID: 4152866
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of neonatal bilateral eye enucleation on postnatal development of the monoamines in posterior thalamus of the rat.
    Vizuete ML; Santiago M; Herrera AJ; Venero JL; Machado A; Cano J
    J Neural Transm Gen Sect; 1991; 85(3):231-42. PubMed ID: 1681825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1974 Jun; 52(3):500-7. PubMed ID: 4152758
    [No Abstract]   [Full Text] [Related]  

  • 17. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of trimipramine, an atypical tricyclic antidepressant, on the activities of various enzymes involved in the metabolism of biogenic amines.
    Yu PH; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):409-16. PubMed ID: 1972801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat.
    Keane PE; Kan JP; Sontag N; Benedetti MS
    J Pharm Pharmacol; 1979 Nov; 31(11):752-4. PubMed ID: 41906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.